{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:47:06Z","timestamp":1790984826625,"version":"4.1.0"},"reference-count":0,"publisher":"American Physiological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"published-print":{"date-parts":[[1996,7,1]]},"abstract":"<jats:p> We studied the mechanism of erythropoietin (EPO)-induced hypertension (HTN) in rats with chronic renal failure (CRF). After partial nephrectomy, rats were randomized into four groups. Group A received EPO, 150 U\/kg, two times weekly for 6 wk to prevent anemia; group B received placebo injections and became anemic; group C received EPO but was kept anemic by dietary iron deficiency; and group D received placebo and regular transfusions to match hematocrit (Hct) in group A. Blood pressure (BP), Hct, platelet cytosolic calcium ([Ca2+]i) and magnesium concentration, and pressor and vasodilatory responses were determined. By design, Hct in groups A and D were comparable and significantly greater (P &lt; 0.01) than in groups B and C. Despite divergent Hct values, the EPO-treated groups A and C showed a significant rise in BP compared with the placebo-treated groups B and D. HTN occurred whether EPO therapy was begun immediately or 4 wk after nephrectomy. EPO therapy augmented the elevation of basal [Ca2+]i and restored the defective thrombin-mediated rise of platelet [Ca2+]i in CRF animals. EPO therapy did not alter caudal artery contraction in response to either 68 mM K(+)-induced depolarization, angiotensin II or alpha 1-agonist, methoxamine in vitro, or the pressor response to angiotensin II in vivo. However, EPO therapy impaired the hypotensive response to nitric oxide (NO) donors, sodium nitroprusside and S-nitroso-N-acetyl-D,L-penicillamine, and reversed the CRF-induced upregulation of guanosine 3',5'-cyclic monophosphate production by thoracic aorta in vitro. Thus EPO-induced HTN in CRF rats is Hct independent and is associated with and perhaps causally related to increased basal and stimulated [Ca2+]i and impaired vasodilatory response to NO. <\/jats:p>","DOI":"10.1152\/ajpendo.1996.271.1.e113","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T05:42:26Z","timestamp":1513921346000},"page":"E113-E122","source":"Crossref","is-referenced-by-count":14,"title":["Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure"],"prefix":"10.1152","volume":"271","author":[{"given":"N. D.","family":"Vaziri","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, Irvine 92717, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. J.","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Irvine 92717, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Naqvi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Irvine 92717, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Irvine 92717, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Oveisi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Irvine 92717, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. Q.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Irvine 92717, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. E.","family":"Purdy","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Irvine 92717, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpendo.1996.271.1.E113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T13:55:03Z","timestamp":1567950903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpendo.1996.271.1.E113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,7,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,7,1]]}},"alternative-id":["10.1152\/ajpendo.1996.271.1.E113"],"URL":"https:\/\/doi.org\/10.1152\/ajpendo.1996.271.1.e113","relation":{},"ISSN":["0193-1849","1522-1555"],"issn-type":[{"value":"0193-1849","type":"print"},{"value":"1522-1555","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,7,1]]}}}